Scaffold-Based (Matrigel™) 3D Culture Technique of Glioblastoma Recovers a Patient-like Immunosuppressive Phenotype

Conventional 2D cultures are commonly used in cancer research though they come with limitations such as the lack of microenvironment or reduced cell heterogeneity. In this study, we investigated in what respect a scaffold-based (Matrigel™) 3D culture technique can ameliorate the limitations of 2D cu...

Full description

Bibliographic Details
Main Authors: Frank K. Braun, Tanja Rothhammer-Hampl, Julia Lorenz, Sandra Pohl, Ayse-Nur Menevse, Arabel Vollmann-Zwerenz, Elisabeth Bumes, Maren Büttner, Saida Zoubaa, Martin Proescholdt, Nils O. Schmidt, Peter Hau, Philipp Beckhove, Beate Winner, Markus J. Riemenschneider
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/12/14/1856
_version_ 1827733518389608448
author Frank K. Braun
Tanja Rothhammer-Hampl
Julia Lorenz
Sandra Pohl
Ayse-Nur Menevse
Arabel Vollmann-Zwerenz
Elisabeth Bumes
Maren Büttner
Saida Zoubaa
Martin Proescholdt
Nils O. Schmidt
Peter Hau
Philipp Beckhove
Beate Winner
Markus J. Riemenschneider
author_facet Frank K. Braun
Tanja Rothhammer-Hampl
Julia Lorenz
Sandra Pohl
Ayse-Nur Menevse
Arabel Vollmann-Zwerenz
Elisabeth Bumes
Maren Büttner
Saida Zoubaa
Martin Proescholdt
Nils O. Schmidt
Peter Hau
Philipp Beckhove
Beate Winner
Markus J. Riemenschneider
author_sort Frank K. Braun
collection DOAJ
description Conventional 2D cultures are commonly used in cancer research though they come with limitations such as the lack of microenvironment or reduced cell heterogeneity. In this study, we investigated in what respect a scaffold-based (Matrigel™) 3D culture technique can ameliorate the limitations of 2D cultures. NGS-based bulk and single-cell sequencing of matched pairs of 2D and 3D models showed an altered transcription of key immune regulatory genes in around 36% of 3D models, indicating the reoccurrence of an immune suppressive phenotype. Changes included the presentation of different HLA surface molecules as well as cellular stressors. We also investigated the 3D tumor organoids in a co-culture setting with tumor-infiltrating lymphocytes (TILs). Of note, lymphocyte-mediated cell killing appeared less effective in clearing 3D models than their 2D counterparts. IFN-γ release, as well as live cell staining and proliferation analysis, pointed toward an elevated resistance of 3D models. In conclusion, we found that the scaffold-based (Matrigel™) 3D culture technique affects the transcriptional profile in a subset of GBM models. Thus, these models allow for depicting clinically relevant aspects of tumor-immune interaction, with the potential to explore immunotherapeutic approaches in an easily accessible in vitro system.
first_indexed 2024-03-11T01:12:26Z
format Article
id doaj.art-34a1a8f1e65a4f44afca380bf5cfda63
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-11T01:12:26Z
publishDate 2023-07-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-34a1a8f1e65a4f44afca380bf5cfda632023-11-18T18:46:09ZengMDPI AGCells2073-44092023-07-011214185610.3390/cells12141856Scaffold-Based (Matrigel™) 3D Culture Technique of Glioblastoma Recovers a Patient-like Immunosuppressive PhenotypeFrank K. Braun0Tanja Rothhammer-Hampl1Julia Lorenz2Sandra Pohl3Ayse-Nur Menevse4Arabel Vollmann-Zwerenz5Elisabeth Bumes6Maren Büttner7Saida Zoubaa8Martin Proescholdt9Nils O. Schmidt10Peter Hau11Philipp Beckhove12Beate Winner13Markus J. Riemenschneider14Department of Neuropathology, Regensburg University Hospital, 93053 Regensburg, GermanyDepartment of Neuropathology, Regensburg University Hospital, 93053 Regensburg, GermanyDepartment of Neuropathology, Regensburg University Hospital, 93053 Regensburg, GermanyDepartment of Neuropathology, Regensburg University Hospital, 93053 Regensburg, GermanyDivision of Interventional Immunology, Leibniz Institute for Immunotherapy, 93053 Regensburg, GermanyDepartment of Neurology and Wilhelm Sander-NeuroOncology Unit, Regensburg University Hospital, 93053 Regensburg, GermanyDepartment of Neurology and Wilhelm Sander-NeuroOncology Unit, Regensburg University Hospital, 93053 Regensburg, GermanyInstitute of Computational Biology, Helmholtz Center Munich, 85764 Munich, GermanyDepartment of Neuropathology, Regensburg University Hospital, 93053 Regensburg, GermanyDepartment of Neurosurgery, Regensburg University Hospital, 93053 Regensburg, GermanyDepartment of Neurosurgery, Regensburg University Hospital, 93053 Regensburg, GermanyDepartment of Neurology and Wilhelm Sander-NeuroOncology Unit, Regensburg University Hospital, 93053 Regensburg, GermanyDivision of Interventional Immunology, Leibniz Institute for Immunotherapy, 93053 Regensburg, GermanyDepartment of Stem Cell Biology, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, 91054 Erlangen, GermanyDepartment of Neuropathology, Regensburg University Hospital, 93053 Regensburg, GermanyConventional 2D cultures are commonly used in cancer research though they come with limitations such as the lack of microenvironment or reduced cell heterogeneity. In this study, we investigated in what respect a scaffold-based (Matrigel™) 3D culture technique can ameliorate the limitations of 2D cultures. NGS-based bulk and single-cell sequencing of matched pairs of 2D and 3D models showed an altered transcription of key immune regulatory genes in around 36% of 3D models, indicating the reoccurrence of an immune suppressive phenotype. Changes included the presentation of different HLA surface molecules as well as cellular stressors. We also investigated the 3D tumor organoids in a co-culture setting with tumor-infiltrating lymphocytes (TILs). Of note, lymphocyte-mediated cell killing appeared less effective in clearing 3D models than their 2D counterparts. IFN-γ release, as well as live cell staining and proliferation analysis, pointed toward an elevated resistance of 3D models. In conclusion, we found that the scaffold-based (Matrigel™) 3D culture technique affects the transcriptional profile in a subset of GBM models. Thus, these models allow for depicting clinically relevant aspects of tumor-immune interaction, with the potential to explore immunotherapeutic approaches in an easily accessible in vitro system.https://www.mdpi.com/2073-4409/12/14/1856brain cancertumor organoidsGBMnext-generation sequencingsingle-cell RNA sequencing
spellingShingle Frank K. Braun
Tanja Rothhammer-Hampl
Julia Lorenz
Sandra Pohl
Ayse-Nur Menevse
Arabel Vollmann-Zwerenz
Elisabeth Bumes
Maren Büttner
Saida Zoubaa
Martin Proescholdt
Nils O. Schmidt
Peter Hau
Philipp Beckhove
Beate Winner
Markus J. Riemenschneider
Scaffold-Based (Matrigel™) 3D Culture Technique of Glioblastoma Recovers a Patient-like Immunosuppressive Phenotype
Cells
brain cancer
tumor organoids
GBM
next-generation sequencing
single-cell RNA sequencing
title Scaffold-Based (Matrigel™) 3D Culture Technique of Glioblastoma Recovers a Patient-like Immunosuppressive Phenotype
title_full Scaffold-Based (Matrigel™) 3D Culture Technique of Glioblastoma Recovers a Patient-like Immunosuppressive Phenotype
title_fullStr Scaffold-Based (Matrigel™) 3D Culture Technique of Glioblastoma Recovers a Patient-like Immunosuppressive Phenotype
title_full_unstemmed Scaffold-Based (Matrigel™) 3D Culture Technique of Glioblastoma Recovers a Patient-like Immunosuppressive Phenotype
title_short Scaffold-Based (Matrigel™) 3D Culture Technique of Glioblastoma Recovers a Patient-like Immunosuppressive Phenotype
title_sort scaffold based matrigel™ 3d culture technique of glioblastoma recovers a patient like immunosuppressive phenotype
topic brain cancer
tumor organoids
GBM
next-generation sequencing
single-cell RNA sequencing
url https://www.mdpi.com/2073-4409/12/14/1856
work_keys_str_mv AT frankkbraun scaffoldbasedmatrigel3dculturetechniqueofglioblastomarecoversapatientlikeimmunosuppressivephenotype
AT tanjarothhammerhampl scaffoldbasedmatrigel3dculturetechniqueofglioblastomarecoversapatientlikeimmunosuppressivephenotype
AT julialorenz scaffoldbasedmatrigel3dculturetechniqueofglioblastomarecoversapatientlikeimmunosuppressivephenotype
AT sandrapohl scaffoldbasedmatrigel3dculturetechniqueofglioblastomarecoversapatientlikeimmunosuppressivephenotype
AT aysenurmenevse scaffoldbasedmatrigel3dculturetechniqueofglioblastomarecoversapatientlikeimmunosuppressivephenotype
AT arabelvollmannzwerenz scaffoldbasedmatrigel3dculturetechniqueofglioblastomarecoversapatientlikeimmunosuppressivephenotype
AT elisabethbumes scaffoldbasedmatrigel3dculturetechniqueofglioblastomarecoversapatientlikeimmunosuppressivephenotype
AT marenbuttner scaffoldbasedmatrigel3dculturetechniqueofglioblastomarecoversapatientlikeimmunosuppressivephenotype
AT saidazoubaa scaffoldbasedmatrigel3dculturetechniqueofglioblastomarecoversapatientlikeimmunosuppressivephenotype
AT martinproescholdt scaffoldbasedmatrigel3dculturetechniqueofglioblastomarecoversapatientlikeimmunosuppressivephenotype
AT nilsoschmidt scaffoldbasedmatrigel3dculturetechniqueofglioblastomarecoversapatientlikeimmunosuppressivephenotype
AT peterhau scaffoldbasedmatrigel3dculturetechniqueofglioblastomarecoversapatientlikeimmunosuppressivephenotype
AT philippbeckhove scaffoldbasedmatrigel3dculturetechniqueofglioblastomarecoversapatientlikeimmunosuppressivephenotype
AT beatewinner scaffoldbasedmatrigel3dculturetechniqueofglioblastomarecoversapatientlikeimmunosuppressivephenotype
AT markusjriemenschneider scaffoldbasedmatrigel3dculturetechniqueofglioblastomarecoversapatientlikeimmunosuppressivephenotype